000			02023nam a22004335i 4500
001			u372439
003			SIRSI
005			20160812084058.0
007			cr nn 008mamaa
008			110910s2011 xxu| s |||| 0|eng d
020			_a9781461406501 _9978-1-4614-0650-1
040			_cMX-MeUAM
050		4	_aQH506
082	0	4	_a611.01816 _223
100	1		_aCowart, L. Ashley. _eeditor.
245	1	0	_aSphingolipids and Metabolic Disease _h[recurso electrónico] / _cedited by L. Ashley Cowart.
264		1	_aNew York, NY : _bSpringer New York, _c2011.
300			_aXVIII, 148p. 26 illus. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aAdvances in Experimental Medicine and Biology, _x0065-2598 ; _v721
505	0		_aSphingolipid Metabolism and Analysis in Metabolic Disease -- Sphingolipids and Cardiovascular Diseases: Lipoprotein Metabolism, Atherosclerosis and Cardiomyopathy -- Heart Sphingolipids in Health and Disease -- Blood Sphingolipids in Homeostasis and Pathobiology -- Adipose Tissue and Ceramide Biosynthesis in the Pathogenesis of Obesity -- Sphingolipids and Hepatic Steatosis -- Glycosphingolipids and Insulin Resistance -- Glyco Sphingolipids and Kidney Disease -- Sphingolipid Synthetic Pathways are Major Regulators of Lipid Homeostasis.
520			_aNo back cover text.
650		0	_aMedicine.
650		0	_aMetabolic diseases.
650	1	4	_aBiomedicine.
650	2	4	_aMolecular Medicine.
650	2	4	_aMetabolic Diseases.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9781461406495
830		0	_aAdvances in Experimental Medicine and Biology, _x0065-2598 ; _v721
856	4	0	_zLibro electrónico _uhttp://148.231.10.114:2048/login?url=http://link.springer.com/book/10.1007/978-1-4614-0650-1
596			_a19
942			_cLIBRO_ELEC
999			_c200319 _d200319